TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06032195: A Prospective Randomized Single Blind Multicenter Phase II Study of Organ Perfusion With Custodiol-N Compared With Custodiol in Heart Transplantation in Children

Sponsor: Dr. F. Köhler Chemie GmbH · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 20 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$6,274,800

Rescue Site Savings

+$4,150,000

Unlock Full NCT06032195 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06032195 Rescue Dossier →